I den første undersøgelser vedrørende nyresygdom var Karvea mere effektivt end placebo til at reducere risikoen for at udvikle nyreskade som målt ved proteinudskillelse.
In the first kidney disease study, Karvea was more effective than placebo at reducing the risk of developing kidney damage as measured by protein excretion.